ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
CELG,Celgene Corporation,151020104,251529000.0,2150186,18.1199234944728,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Isis Pharmaceuticals, Inc.",464330109,208758000.0,7769172,15.038739027544151,2013-08-14,2013-06-30,0000950123-13-006435
GILD,"Gilead Sciences, Inc.",375558103,189699000.0,3700000,13.665745766802221,2013-08-14,2013-06-30,0000950123-13-006435
INCY,Incyte Corporation,45337C102,117857000.0,5357149,8.490312541647606,2013-08-14,2013-06-30,0000950123-13-006435
VRTX,Vertex Pharmaceuticals Incorporated,92532F100,112440000.0,1404445,8.100076721644509,2013-08-14,2013-06-30,0000950123-13-006435
ALXN,"Alexion Pharmaceuticals, Inc.",015351109,71774000.0,778126,5.170534566162513,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Medivation, Inc.",58501N101,71326000.0,1449706,5.138261048096907,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Ariad Pharmaceuticals, Inc",04033A100,54488000.0,3115371,3.925266634729331,2013-08-14,2013-06-30,0000950123-13-006435
IMGNEUR,"Immunogen, Inc.",45253H101,54118000.0,3262094,3.8986121666840763,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Onyx Pharmaceuticals, Inc.",683399109,47447000.0,546500,3.4180393117384114,2013-08-14,2013-06-30,0000950123-13-006435
HALO,"Halozyme Therapeutics, Inc.",40637H109,44890000.0,5646519,3.2338353258148524,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Theravance, Inc.",88338T104,34224000.0,888244,2.465466255083259,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Endocyte, Inc.",29269A102,30716000.0,2339345,2.212753082373112,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Optimer Pharmaceuticals, Inc.",68401H104,20934000.0,1446700,1.5080665785388307,2013-08-14,2013-06-30,0000950123-13-006435
INFIQ,"Infinity Pharmaceuticals, Inc.",45665G303,17646000.0,1089828,1.271202008450187,2013-08-14,2013-06-30,0000950123-13-006435
ALNY,"Alnylam Pharmaceuticals, Inc.",02043Q107,14099000.0,454800,1.015679310729864,2013-08-14,2013-06-30,0000950123-13-006435
ACHNEUR,"Achillion Pharmaceuticals, Inc",00448Q201,13737000.0,1679340,0.9896011555072094,2013-08-14,2013-06-30,0000950123-13-006435
BMRN,Biomarin Pharmaceutical Inc,09061G101,9923000.0,178028,0.7148440173326082,2013-08-14,2013-06-30,0000950123-13-006435
MDCOUSD,The Medicines Company,584688105,9320000.0,302993,0.6714044383291251,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Idenix Pharmaceuticals, Inc.",45166R204,4513000.0,1250000,0.3251124710492856,2013-08-14,2013-06-30,0000950123-13-006435
N/A,Dendreon Corporation,24823Q107,4181000.0,1014800,0.3011954889113811,2013-08-14,2013-06-30,0000950123-13-006435
N/A,"Trius Therapeutics, Inc.",89685K100,2268000.0,280000,0.16338468520713043,2013-08-14,2013-06-30,0000950123-13-006435
N/A,Synageva BioPharma Corp.,87159A103,2248000.0,53549,0.16194390315063015,2013-08-14,2013-06-30,0000950123-13-006435
